https://mabsolve.com/novalgen-licenses-mabsolves-technology-to-improve-the-safety-of-therapeutic-antibodies/2021-12-10T14:07:16+00:00https://mabsolve.com/mabsolve-spins-out-of-absolute-antibody-with-novel-fc-silencing-technology/2021-12-06T15:25:27+00:00https://mabsolve.com/mabsolve-files-patent-on-novel-fc-silencing-technology/2021-12-06T15:25:22+00:00https://mabsolve.com/mabsolve-launches-str-a-novel-fc-silencing-technology-available-to-licence/2021-12-06T15:25:17+00:00https://mabsolve.com/prof-geoff-hale-to-present-at-biologics-symposium-2020/2021-12-06T15:28:03+00:00https://mabsolve.com/prof-geoff-hale-to-present-at-mastering-immunity-europe-2021/2021-12-06T15:27:50+00:00https://mabsolve.com/mabsolve-files-international-patent-application/2021-12-06T15:29:32+00:00https://mabsolve.com/prof-geoff-hale-to-present-at-antibody-drug-development-summit-2021/2021-12-06T15:30:32+00:00https://mabsolve.com/dr-ian-wilkinson-joins-mabsolve-as-chief-scientific-officer/2021-12-06T15:31:23+00:00https://mabsolve.com/mabsolves-str-patent-application-published/2021-12-06T15:32:34+00:00https://mabsolve.com/mabsolve-launches-updated-website/2021-12-06T15:36:42+00:00https://mabsolve.com/mabsolve-quarterly-company-update/2021-12-06T15:36:23+00:00https://mabsolve.com/str-silencing-published-in-plos-one/2022-02-19T11:06:35+00:00https://mabsolve.com/ona-therapeutics-sign-licence-to-str-technology/2022-02-19T11:07:24+00:00https://mabsolve.com/mabsolve-quarterly-company-update-2/2022-03-04T12:39:27+00:00https://mabsolve.com/evitria-ag-announces-license-of-mabsolve-str-technology/2022-05-09T11:03:57+01:00https://mabsolve.com/absolute-antibody-licenses-novel-fc-silencing-technology-from-mabsolve/2022-03-30T09:10:52+01:00https://mabsolve.com/mabsolve-to-present-webinar-hosted-by-the-antibody-society/2022-04-07T12:20:41+01:00https://mabsolve.com/mabsolve-to-present-str-technology-at-pegs-boston-2022/2022-05-09T11:07:01+01:00https://mabsolve.com/antibody-analytics-licenses-novel-fc-silencing-technology-from-mabsolve/2022-06-06T13:21:41+01:00https://mabsolve.com/scancell-license-str-technology/2022-06-23T12:35:31+01:00https://mabsolve.com/patent-granted-for-mabsolves-fc-silencing-technology/2022-07-19T12:52:18+01:00https://mabsolve.com/ian-wilkinson-to-give-webinar-to-chinese-antibody-society/2022-09-07T12:33:39+01:00https://mabsolve.com/mabsolve-publish-paper-in-mabs/2022-09-16T12:13:28+01:00https://mabsolve.com/geoff-hale-to-present-at-promega-biologics-symposium/2022-09-21T15:02:24+01:00https://mabsolve.com/genscript-probio-licences-str-technology-from-mabsolve/2022-11-28T13:39:07+00:00https://mabsolve.com/geoff-hale-confirmed-as-keynote-speaker-at-aet-2023/2023-02-06T13:15:46+00:00https://mabsolve.com/omniab-license-str-technology-from-mabsolve/2023-02-23T18:03:20+00:00https://mabsolve.com/mhra-licenses-novel-fc-silencing-technology-from-mabsolve/2023-06-12T09:48:54+01:00https://mabsolve.com/mabsolve-to-exhibit-at-festival-of-biologics-2023/2023-07-19T14:03:58+01:00https://mabsolve.com/use-of-str-in-an-fc-fusion-protein-being-developed-for-covid-19-published/2023-08-23T14:59:40+01:00https://mabsolve.com/antibody-solutions-licenses-str-from-mabsolve/2023-12-05T13:49:07+00:00https://mabsolve.com/mabsolve-patent-update/2024-07-18T11:22:10+01:00https://mabsolve.com/umass-chan-medical-school-licenses-str/2024-08-22T11:34:13+01:00https://mabsolve.com/living-in-lala-land/2024-09-25T14:56:16+01:00https://mabsolve.com/systematic-analysis-of-fc-silencing-mutations/2026-04-04T11:27:32+01:00